Verastem (VSTM)

[stockguard]

Both analyst have lowered their price targets for now but I see them raising likely again as sales progress and ongoing trials start proving out going forward.

Verastem analyst commentary at H.C. Wainwright Verastem price target lowered to $10 from $13 at H.C. Wainwright. H.C. Wainwright analyst Swayampakula Ramakanth lowered his price target for Verastem to $10 from $13 saying that while the Copiktra launch progressing, the early ramp is slower than expected. The analyst, however, continues to believe in the long-term potential of Copiktra and reiterates a Buy rating on the shares.

Verastem Is Maintained at Outperform by Raymond James
March 14, 2019 Verastem Is Maintained at Outperform by Raymond James
DJ Verastem Price Target Cut to $6.00/Share From $12.00 by Raymond James